Viewing Study NCT00288067


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-03 @ 8:19 PM
Study NCT ID: NCT00288067
Status: TERMINATED
Last Update Posted: 2014-10-06
First Post: 2006-02-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma View
None B-cell Chronic Lymphocytic Leukemia View
None Contiguous Stage II Adult Burkitt Lymphoma View
None Contiguous Stage II Adult Diffuse Large Cell Lymphoma View
None Contiguous Stage II Adult Lymphoblastic Lymphoma View
None Contiguous Stage II Grade 1 Follicular Lymphoma View
None Contiguous Stage II Grade 2 Follicular Lymphoma View
None Contiguous Stage II Mantle Cell Lymphoma View
None Stage II Marginal Zone Lymphoma View
None Stage II Small Lymphocytic Lymphoma View
None Extranodal Marginal Zone B-cell Lymphoma View
None Nodal Marginal Zone B-cell Lymphoma View
None Noncontiguous Stage II Adult Burkitt Lymphoma View
None Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma View
None Noncontiguous Stage II Adult Lymphoblastic Lymphoma View
None Noncontiguous Stage II Grade 1 Follicular Lymphoma View
None Noncontiguous Stage II Grade 2 Follicular Lymphoma View
None Noncontiguous Stage II Mantle Cell Lymphoma View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Adult Hodgkin Lymphoma View
None Recurrent Adult Lymphoblastic Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Marginal Zone Lymphoma View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Splenic Marginal Zone Lymphoma View
None Stage I Adult Burkitt Lymphoma View
None Stage I Adult Diffuse Large Cell Lymphoma View
None Stage I Adult Hodgkin Lymphoma View
None Stage I Adult Lymphoblastic Lymphoma View
None Stage I Chronic Lymphocytic Leukemia View
None Stage I Grade 1 Follicular Lymphoma View
None Stage I Grade 2 Follicular Lymphoma View
None Stage I Small Lymphocytic Lymphoma View
None Stage II Adult Hodgkin Lymphoma View
None Stage II Chronic Lymphocytic Leukemia View
None Stage III Adult Burkitt Lymphoma View
None Stage III Adult Diffuse Large Cell Lymphoma View
None Stage III Adult Hodgkin Lymphoma View
None Stage III Adult Lymphoblastic Lymphoma View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Grade 1 Follicular Lymphoma View
None Stage III Grade 2 Follicular Lymphoma View
None Stage III Mantle Cell Lymphoma View
None Stage III Marginal Zone Lymphoma View
None Stage III Small Lymphocytic Lymphoma View
None Stage IV Adult Burkitt Lymphoma View
None Stage IV Adult Diffuse Large Cell Lymphoma View
None Stage IV Adult Hodgkin Lymphoma View
None Stage IV Adult Lymphoblastic Lymphoma View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Grade 1 Follicular Lymphoma View
None Stage IV Grade 2 Follicular Lymphoma View
None Stage IV Mantle Cell Lymphoma View
None Stage IV Marginal Zone Lymphoma View
None Stage IV Small Lymphocytic Lymphoma View
None Waldenström Macroglobulinemia View
Keywords: